{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:22:12Z","timestamp":1785608532661,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"MHLW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"MHLW","doi-asserted-by":"publisher","award":["H23-shinkou-ippan-010"],"award-info":[{"award-number":["H23-shinkou-ippan-010"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"MHLW","doi-asserted-by":"publisher","award":["H23-seisakutansaku-ippan-002"],"award-info":[{"award-number":["H23-seisakutansaku-ippan-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.06.017","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T13:30:46Z","timestamp":1403011846000},"page":"4289-4295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays"],"prefix":"10.1016","volume":"32","author":[{"given":"Atsushi","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.06.017_bib0005","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0010","series-title":"Fields virology (sixth edition)","first-page":"747","article-title":"Flaviviruses","author":"Pierson","year":"2013"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0015","series-title":"Dengue and severe dengue","author":"World Health Organization Fact sheet No. 117","year":"2013"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","article-title":"Global spread of dengue virus types: mapping the 70 year history","volume":"22","author":"Messina","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.meegid.2009.02.003","article-title":"Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease","volume":"9","author":"Weaver","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3201\/eid0907.030038","article-title":"Emergence and global spread of a dengue serotype 3, subtype III virus","volume":"9","author":"Messer","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0035","first-page":"16501658","article-title":"Selection-driven evolution of emergent dengue virus","volume":"20","author":"Bennett","year":"2000","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0040","doi-asserted-by":"crossref","first-page":"e27322","DOI":"10.1371\/journal.pone.0027322","article-title":"Displacement of the predominant dengue virus from type 2 to type 1 with a subsequent genotype shift from IV to I in Surabaya, Indonesia 2008\u20132010","volume":"6","author":"Yamanaka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0045","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.meegid.2011.03.025","article-title":"The origin of dengue viruses caused the DF outbreak in Guangdong province, China, in 2006","volume":"11","author":"Chen","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0050","doi-asserted-by":"crossref","first-page":"20532055","DOI":"10.3201\/eid1711.101893","article-title":"New dengue virus type 1 genotype in Colombo, Sri Lanka","volume":"17","author":"Tissera","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.meegid.2011.10.012","article-title":"Dengue virus surveillance in Singapore reveals high viral diversity through multiple introductions and in situ evolution","volume":"12","author":"Lee","year":"2012","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0060","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.342.6157.415","article-title":"Tropical medicine, Surprising new dengue virus throws a spanner in disease control efforts","volume":"342","author":"Normile","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.coviro.2013.05.014","article-title":"Challenges in the clinical development of a dengue vaccine","volume":"3","author":"Wallace","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0070","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.vaccine.2014.01.040","article-title":"A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available","volume":"32","author":"Ishikawa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0075","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S1462399408000665","article-title":"Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection","volume":"10","author":"Pierson","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0882-4010(87)90056-8","article-title":"Profiles of antibody-dependent enhancement of dengue virus type 2 infection","volume":"3","author":"Morens","year":"1987","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0085","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.vaccine.2008.10.087","article-title":"Vaccine-induced enhancement of viral infections","volume":"27","author":"Huisman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0090","doi-asserted-by":"crossref","first-page":"43014306","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0100","series-title":"Security Export Control System in Japan","author":"Ministry of Economy, Trade and Industry of Japan","year":"2009"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0105","series-title":"Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization to the Convention on Biological Diversity","author":"United Nations","year":"2011"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-1119(95)00332-Z","article-title":"Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain)","volume":"162","author":"Kapoor","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/viro.1997.8500","article-title":"Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53","volume":"230","author":"Kinney","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1008160123754","article-title":"Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain","volume":"20","author":"Puri","year":"2000","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0125","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1099\/vir.0.81958-0","article-title":"Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation","volume":"87","author":"Pierro","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1099\/vir.0.058008-0","article-title":"Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon","volume":"95","author":"Suzuki","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1128\/JVI.00992-07","article-title":"Infection\u2013enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels","volume":"82","author":"Yamanaka","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0140","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2005.11.002","article-title":"Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice","volume":"24","author":"Konishi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0145","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4269\/ajtmh.2009.80.856","article-title":"Prevalence of antibodies to Japanese encephalitis virus among inhabitants in Java Island, Indonesia, with a small pig population","volume":"80","author":"Konishi","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0150","doi-asserted-by":"crossref","first-page":"12828","DOI":"10.1128\/JVI.01874-13","article-title":"A mouse monoclonal antibody against dengue virus type 1 Mochizuki strain targeting envelope protein domain II and displaying strongly neutralizing but not enhancing activity","volume":"87","author":"Yamanaka","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.7883\/yoken.JJID.2008.410","article-title":"Vero cells infected with vaccinia viruses expressing Japanese encephalitis virus envelope protein induce polykaryocyte formation under neutral conditions","volume":"61","author":"Konishi","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0160","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JCM.42.11.5087-5093.2004","article-title":"Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses","volume":"42","author":"Konishi","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0165","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jviromet.2009.10.026","article-title":"A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells","volume":"163","author":"Konishi","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0170","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0175","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1586\/14760584.2013.815412","article-title":"Dengue vaccines: recent developments, ongoing challenges and current candidates","volume":"12","author":"McArthur","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4269\/ajtmh.2009.80.61","article-title":"An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells","volume":"80","author":"Rodrigo","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0185","doi-asserted-by":"crossref","first-page":"e1536","DOI":"10.1371\/journal.pntd.0001536","article-title":"Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcgammaR-expressing cells","volume":"6","author":"Moi","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0195","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0042-6822(91)90788-D","article-title":"Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus","volume":"185","author":"Konishi","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<76::AID-JMV12>3.0.CO;2-4","article-title":"Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis","volume":"48","author":"Konishi","year":"1996","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2014.06.017_bib0205","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CVI.00004-08","article-title":"Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections","volume":"15","author":"Chiou","year":"2008","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T09:41:42Z","timestamp":1689327702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14008068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":41,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14008068"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}